Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios | National Resource for Infection Control (NRIC)

Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios

Journal article, Research study
Abstract: 
A new study from Public Health England (PHE) published in the Journal of Hepatology has looked at the cost of increasing hepatitis C treatment uptake in England, and the impact this would have on disease burden.
Authors: 
Ross J. HarrisBrenda ThomasJade GriffithsAnnastella CostellaRuth ChapmanMary RamsayDaniela De AngelisHelen E. Harris - Journal of Hepatology Available online 10 May 2014
Category: 
Economic analysis
Epidemiology